Erectile Dysfunction Completed Phase 3 Trials for Dapoxetine (DB04884)

Also known as: EDS / ED / Erectile difficulties / Erectile Dysfunction (ED) / Difficulty maintaining an erection / Decreased erections / Male Erectile Disorder / Male Erectile Dysfunction / Difficult erection / Inability to achieve or maintain erection / Erectile Dysfunctions / Male erectile dysfunction, unspecified / Erectile dysfunction (disorder) / Impotence / Erectile dysfunction NOS / Impotent / Erectile disturbance / Erection failure / Psychogenic impotence

IndicationStatusPhase
DBCOND0029956 (Erectile Dysfunction)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01230762An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid EjaculationTreatment
NCT01063855Concomitant Use of PriLigy in Men Treated for Erectile DysfunctionTreatment
NCT00229073A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature EjaculationTreatment
NCT00210704A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature EjaculationTreatment